huberman glp-1 New Lab podcast out now: THE SCIENCE OF HUNGER & MEDICATIONS TO COMBAT OBESITY with Dr Zachary Knight of @ucsfmedicine Andrew Huberman Discusses Ozempic and

This last point is legally significant because it undermines the argument that the vision loss is caused by underlying diabetes rather than the medication itself

Data from large-scale cardiovascular outcome trials indicate up to 13% of people on GLP-1 receptor agonists discontinue these agents due to adverse GI effects

However, further studies on humans are necessary to confirm whether microneedle patches aid weight loss

10,11 This body of work has been instrumental in defining how individual cells cross the ferroptotic threshold, although it is increasingly evident that this threshold varies widely across cell types, metabolic states, and tissue contexts

But all that's to say, rather than generating conspiracy theories about evil Big Pharma or like doctors doing bad things, I think the most productive way to look at it is what are the incentive structures that have gotten us to where we are and recognizing what are the limitations of what we call evidence-based care